265 related articles for article (PubMed ID: 9585004)
1. Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.
Schadewaldt P; Bodner A; Brösicke H; Hammen HW; Wendel U
Pediatr Res; 1998 May; 43(5):592-600. PubMed ID: 9585004
[TBL] [Abstract][Full Text] [Related]
2. Practical methods to estimate whole body leucine oxidation in maple syrup urine disease.
Elsas LJ; Ellerine NP; Klein PD
Pediatr Res; 1993 May; 33(5):445-51. PubMed ID: 8511017
[TBL] [Abstract][Full Text] [Related]
3. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.
Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
Pediatr Res; 2001 May; 49(5):627-35. PubMed ID: 11328944
[TBL] [Abstract][Full Text] [Related]
4. Domino liver transplantation in maple syrup urine disease.
Khanna A; Hart M; Nyhan WL; Hassanein T; Panyard-Davis J; Barshop BA
Liver Transpl; 2006 May; 12(5):876-82. PubMed ID: 16628687
[TBL] [Abstract][Full Text] [Related]
5. Protein and leucine metabolism in maple syrup urine disease.
Thompson GN; Bresson JL; Pacy PJ; Bonnefont JP; Walter JH; Leonard JV; Saudubray JM; Halliday D
Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
[TBL] [Abstract][Full Text] [Related]
6. Glucose and alanine metabolism in children with maple syrup urine disease.
Haymond MW; Ben-Galim E; Strobel KE
J Clin Invest; 1978 Aug; 62(2):398-405. PubMed ID: 670400
[TBL] [Abstract][Full Text] [Related]
7. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
8. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
[TBL] [Abstract][Full Text] [Related]
9. Application of a [13CO2] breath test to study short-term amino acid catabolism during the postprandial phase of a meal.
Bujko J; Schreurs VV; Nolles JA; Verreijen AM; Koopmanschap RE; Verstegen MW
Br J Nutr; 2007 May; 97(5):891-7. PubMed ID: 17381966
[TBL] [Abstract][Full Text] [Related]
10. Gender affects 13C-ketoisocaproic acid breath test.
Candelli M; Armuzzi A; Miele L; Nista EC; Pignataro G; Zileri Dal Verme L; Grieco A; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2007; 11(6):401-6. PubMed ID: 18306908
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin on leucine kinetics in maple syrup urine disease.
Collins JE; Umpleby AM; Boroujerdi MA; Leonard JV; Sonksen PH
Pediatr Res; 1987 Jan; 21(1):10-3. PubMed ID: 3540829
[TBL] [Abstract][Full Text] [Related]
12. Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.
Bodner-Leidecker A; Wendel U; Saudubray JM; Schadewaldt P
J Inherit Metab Dis; 2000 Dec; 23(8):805-18. PubMed ID: 11196106
[TBL] [Abstract][Full Text] [Related]
13. Whole body leucine metabolism during and after resistance exercise in fed humans.
Tarnopolsky MA; Atkinson SA; MacDougall JD; Senor BB; Lemon PW; Schwarcz H
Med Sci Sports Exerc; 1991 Mar; 23(3):326-33. PubMed ID: 2020271
[TBL] [Abstract][Full Text] [Related]
14. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
15. [End product enrichment changes of tracer leucine under the status of infusion and analysis on 13CO2 production rate].
Ji Y; Piao J; Zhang Y; Gou L
Wei Sheng Yan Jiu; 2009 May; 38(3):363-6. PubMed ID: 19548586
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
17. [Leucinose. II. Study of heterozygotes].
Fontaine G; Dautrevaux M; Farriaux JP; Biserte G
Lille Med; 1967 Apr; 12(4):480-3. PubMed ID: 5619112
[No Abstract] [Full Text] [Related]
18. 13C-methionine breath tests for mitochondrial liver function assessment.
Candelli M; Miele L; Armuzzi A; Nista EC; Pignataro G; Fini L; Cazzato IA; Zocco MA; Bartolozzi F; Gasbarrini G; Grieco A; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2008; 12(4):245-9. PubMed ID: 18727456
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of branched-chain amino acids in maple syrup urine disease.
Schadewaldt P; Wendel U
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
[TBL] [Abstract][Full Text] [Related]
20. Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.
Hoffmann B; Helbling C; Schadewaldt P; Wendel U
Pediatr Res; 2006 Jan; 59(1):17-20. PubMed ID: 16326996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
